Related Experiment Video
Updated: Oct 10, 2025
10:29
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
8.0K
Tuberculosis and pharmacological interactions: A narrative review.
Niccolò Riccardi1,2, Diana Canetti1,3, Paola Rodari2
1StopTB Italia Onlus, Milan, Italy.
Current Research in Pharmacology and Drug Discovery
|December 15, 2021
Summary
Managing drug-drug interactions (DDIs) is crucial for improving tuberculosis (TB) treatment success and patient quality of life. This guide details key DDIs between anti-TB drugs and common medications to minimize adverse effects and treatment failures.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Tuberculosis (TB) remains a leading infectious cause of death globally, despite therapeutic advancements.
- Effective TB treatment requires careful management of drug-drug interactions (DDIs) to improve outcomes and patient quality of life.
Purpose of the Study:
- To provide a comprehensive and user-friendly guide on relevant DDIs between anti-TB drugs and commonly prescribed medications.
- To minimize adverse effects, treatment drop-outs, and ultimately enhance TB treatment success.
Main Methods:
- Review of pharmacokinetic and pharmacodynamic (PK/PD) parameters of anti-TB drugs.
- Analysis of potential patient-specific factors affecting drug absorption and distribution.
- Identification and description of significant DDIs encountered in daily clinical practice.
Main Results:
- Detailed description of key DDIs between anti-TB agents and other drugs.
- Guidance on optimizing anti-TB regimens based on DDI knowledge.
- Emphasis on adherence to international guidelines for effective TB management.
Conclusions:
- Wise management of DDIs is essential for successful TB treatment and improved patient outcomes.
- An updated, easy-to-use guide can help clinicians minimize adverse events and treatment failures.
- Optimizing anti-TB therapy through DDI awareness can reduce mortality and improve quality of life.
Related Concept Videos
01:28Pulmonary Tuberculosis V
263
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
263
01:25Pharmacokinetics: Drug–Drug Interactions
15
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
15
01:29Pulmonary Tuberculosis I
389
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
389
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
11
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
11
01:27Combined Effects of Drugs: Synergism
5.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
5.1K
01:26Pulmonary Tuberculosis IV
225
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
225